Mode
Text Size
Log in / Sign up

Pitaya by-products show antioxidant, anti-inflammatory, hypolipidemic, and hypoglycemic potential in systematic reviewPitaya By-products Show Potential for Managing Blood Sugar and Cholesterol

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret pitaya by-products' metabolic benefits as preclinical; clinical translation is unclear.

This systematic review synthesizes evidence on the chemical composition, biological activity, and food industry applications of pitaya (Selenicereus spp.) by-products, including peel, seeds, stem, and flower. The review covers studies reporting on polyphenols, flavonoids, betalains, polysaccharides, and unsaturated fatty acids, as well as antioxidant, anti-inflammatory, hypolipidemic, and hypoglycemic effects.

Key findings indicate that pitaya by-products are rich in bioactive compounds and exhibit multiple biological activities in preclinical models. However, the authors note that mechanistic analyses remain largely correlational, key pathway alterations are inconsistent across different experimental models, and the translational relationship between in vitro activity and in vivo efficacy is currently unclear.

Limitations include the lack of clinical data, absence of reported sample sizes or study populations, and no comparator or safety data. The review suggests potential for pitaya by-products to be transformed into functional food ingredients and bioactive materials, but this remains speculative without human studies.

Clinicians should interpret these findings cautiously, as the evidence is preclinical and does not support direct clinical recommendations for hyperlipidemia or hyperglycemia management.

How this fits prior evidence

This systematic review extends prior coverage on metabolic risk factors by exploring a novel dietary source. While prior items addressed pharmacologic interventions (cerivastatin, simvastatin, rosuvastatin) and lifestyle factors (ultramarathon running, sleep apnea), this review focuses on pitaya by-products as a potential nutraceutical. It addresses a gap in natural product research for hyperlipidemia and hyperglycemia, but the preclinical nature contrasts with the clinical trial evidence for statins and the observational data on sleep apnea. The findings are preliminary and do not yet bridge to clinical practice.

Researchers reviewed the chemical makeup and biological activities of pitaya by-products, which include the peel, seeds, stem, and flower. These parts are rich in natural compounds such as polyphenols, flavonoids, betalains, and unsaturated fatty acids.

The review found that these specific components show antioxidant and anti-inflammatory effects. Additionally, the study noted that pitaya by-products showed hypolipidemic and hypoglycemic effects, which relate to managing fat levels and blood sugar. These findings suggest that waste products from the fruit could be used to create functional food ingredients.

It is important to note that much of this research is currently based on laboratory models rather than human clinical trials. The link between these laboratory results and how they work in the human body is not yet clear. Because the evidence is still early and primarily focused on chemical properties, these findings are not yet ready to change standard medical treatments.

What this means for you:
Pitaya by-products show potential for managing blood sugar and lipids, but more human studies are needed.

Common questions

What parts of the pitaya fruit were studied?

The study looked at various by-products of the pitaya fruit, specifically the peel, seeds, stem, and flower. These parts contain high amounts of polyphenols, flavonoids, betalains, polysaccharides, and unsaturated fatty acids.

Can pitaya by-products help with high blood sugar or cholesterol?

The review found that these by-products exhibit hypolipidemic and hypoglycemic effects. This means they showed potential to help manage fat levels and blood sugar in laboratory settings, though more research is needed to see how they work in humans.

Are these findings ready to be used as a treatment?

Not yet. The study notes that the relationship between lab results and actual effectiveness in the human body is currently unclear. These findings are early and suggest potential for future food ingredients rather than immediate medical use.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Pitaya (Selenicereus spp.) is primarily consumed for its flesh, whereas by-products—including the peel, seeds, stem, and flower—are largely discarded, resulting in resource wastage and environmental burden. This review discusses its chemical composition, mechanism of action, biological activity, and applications in the food industry. By-products of Pitaya are rich in bioactive constituents, such as polyphenols, flavonoids, betalains, polysaccharides, and unsaturated fatty acids. They also exhibit biological activities including antioxidant, anti-inflammatory, hypolipidemic, and hypoglycemic effects. High-value utilization of these by-products is currently at a critical stage of industrial translation. Accordingly, this review systematically synthesizes research findings from multiple disciplines, including phytochemistry, food science, pharmacology, and materials science. These findings are integrated along three principal axes: chemical composition, biological activity, and food application, thereby bridging the logical gap between fundamental research and industrial application. Based on this, we identified the principal limitations of the current research: mechanistic analyses remain largely correlational, key pathway alterations are inconsistent across different experimental models, and the translational relationship between in vitro activity and in vivo efficacy remains unclear. Future studies should conduct standardized human clinical trials, employ multi-omics approaches to elucidate the interactions between bioactive constituents and the gut microbiota, optimize stabilization technologies such as encapsulation, and establish low-energy extraction processes and quality grading standards. This will facilitate the transformation of pitaya from a fresh fruit into functional food ingredients and bioactive materials.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.